Erythropoietin: structure, control of production, and function W Jelkmann Physiological reviews 72 (2), 449-489, 1992 | 1501 | 1992 |
Role of blood platelets in infection and inflammation MHF Klinger, W Jelkmann Journal of interferon & cytokine research 22 (9), 913-922, 2002 | 714 | 2002 |
Regulation of erythropoietin production W Jelkmann The Journal of physiology 589 (6), 1251-1258, 2011 | 708 | 2011 |
Interleukin-1β and Tumor Necrosis Factor- Stimulate DNA Binding of Hypoxia-Inducible Factor-1 T Hellwig-Bürgel, K Rutkowski, E Metzen, J Fandrey, W Jelkmann Blood, The Journal of the American Society of Hematology 94 (5), 1561-1567, 1999 | 681 | 1999 |
Intracellular localisation of human HIF-1α hydroxylases: implications for oxygen sensing E Metzen, U Berchner-Pfannschmidt, P Stengel, JH Marxsen, I Stolze, ... Journal of cell science 116 (7), 1319-1326, 2003 | 620 | 2003 |
Molecular biology of erythropoietin W Jelkmann Internal medicine 43 (8), 649-659, 2004 | 586 | 2004 |
Nitric oxide impairs normoxic degradation of HIF-1α by inhibition of prolyl hydroxylases E Metzen, J Zhou, W Jelkmann, J Fandrey, B Brune Molecular biology of the cell 14 (8), 3470-3481, 2003 | 543 | 2003 |
Proinflammatory cytokines lowering erythropoietin production W Jelkmann Journal of Interferon & Cytokine Research 18 (8), 555-559, 1998 | 523 | 1998 |
Erythropoietin after a century of research: younger than ever W Jelkmann European journal of haematology 78 (3), 183-205, 2007 | 518 | 2007 |
Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-α-prolyl-4-hydroxylases JH Marxsen, P Stengel, K Doege, P Heikkinen, T Jokilehto, T Wagner, ... Biochemical Journal 381 (3), 761-767, 2004 | 435 | 2004 |
Pitfalls in the measurement of circulating vascular endothelial growth factor W Jelkmann Clinical chemistry 47 (4), 617-623, 2001 | 432 | 2001 |
Normoxic induction of the hypoxia-inducible factor 1α by insulin and interleukin-1β involves the phosphatidylinositol 3-kinase pathway DP Stiehl, W Jelkmann, RH Wenger, T Hellwig-Bürgel FEBS letters 512 (1-3), 157-162, 2002 | 398 | 2002 |
Review: Hypoxia-Inducible Factor-1 (HIF-1): A Novel Transcription Factor in Immune Reactions T Hellwig-Bürgel, DP Stiehl, AE Wagner, E Metzen, W Jelkmann Journal of interferon & cytokine research 25 (6), 297-310, 2005 | 339 | 2005 |
Physiology and pharmacology of erythropoietin W Jelkmann Transfusion Medicine and Hemotherapy 40 (5), 302-309, 2013 | 318 | 2013 |
Role of hydrogen peroxide in hypoxia-induced erythropoietin production J Fandrey, S Frede, W Jelkmann Biochemical Journal 303 (2), 507-510, 1994 | 282 | 1994 |
Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys W Jelkmann, H Pagel, M Wolff, J Fandrey Life sciences 50 (4), 301-308, 1992 | 263 | 1992 |
Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element E Metzen, DP Stiehl, K Doege, JH Marxsen, T Hellwig-Bürgel, ... Biochemical Journal 387 (3), 711-717, 2005 | 260 | 2005 |
Inhibition of erythropoietin gene expression signaling involves the transcription factors GATA‐2 and NF‐κB K La Ferla, C Reimann, W Jelkmann, T Hellwig‐Bürgel The FASEB Journal 16 (13), 1-17, 2002 | 221 | 2002 |
Pericellular PO2 and O2 consumption in monolayer cell cultures E Metzen, M Wolff, J Fandrey, W Jelkmann Respiration physiology 100 (2), 101-106, 1995 | 210 | 1995 |
The erythropoietin receptor in normal and cancer tissues W Jelkmann, J Bohlius, M Hallek, AJ Sytkowski Critical reviews in oncology/hematology 67 (1), 39-61, 2008 | 206 | 2008 |